Working… Menu
Trial record 57 of 855 for:    LENALIDOMIDE AND Angiogenesis

A Study of Lenalidomide for Adult Histiocyte Disorders

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02523040
Recruitment Status : Active, not recruiting
First Posted : August 14, 2015
Last Update Posted : October 30, 2018
Information provided by (Responsible Party):
Eric Jacobsen, MD, Dana-Farber Cancer Institute

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : August 2019
Estimated Study Completion Date : August 2022